Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2026 Earnings Call Transcript May 7, 2026
Xenon Pharmaceuticals Inc. reports earnings inline with expectations. Reported EPS is $-1.17 EPS, expectations were $-1.17.
Operator: Thank you for standing by. My name is Rebecca, and I will be your conference operator today. At this time, I would like to welcome everyone to the First Quarter 2026 Xenon Pharmaceuticals Inc. Earnings Conference Call. All lines have been placed on mute to prevent any...
